Publications
-
CD137 ligand is expressed in primary and secondary lymphoid follicles and in B-cell lymphomas: diagnostic and therapeutic implications.
Zhao S,
Zhang H, Xing Y, Natkunam Y.
Am J Surg Pathol.
2013;
37
(2):
250-8
-
Germinal centre protein HGAL promotes lymphoid hyperplasia and amyloidosis via BCR-mediated Syk activation.
Romero-Camarero I,
Jiang X, Natkunam Y, Lu X, Vicente-Dueñas C, Gonzalez-Herrero I, Flores T, Garcia JL, McNamara G, Kunder C, Zhao S, Segura V, Fontan L, Martínez-Climent JA, García-Criado FJ, Theis JD, Dogan A, Campos-Sánchez E, Green MR, Alizadeh AA, Cobaleda C, Sánchez-García I, Lossos IS.
Nat Commun.
2013:
4
1338
-
CD137 is expressed in follicular dendritic cell tumors and in classical Hodgkin and T-cell lymphomas: diagnostic and therapeutic implications.
Anderson MW,
Zhao S, Freud AG, Czerwinski DK, Kohrt H, Alizadeh AA, Houot R, Azambuja D, Biasoli I, Morais JC, Spector N, Molina-Kirsch HF, Warnke RA, Levy R, Natkunam Y.
Am J Pathol.
2012;
181
(3):
795-803
-
Clinicopathological features of aggressive B-cell lymphomas including B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell and Burkitt lymphomas: a study of 44 patients from Argentina.
Bürgesser MV,
Gualco G, Diller A, Natkunam Y, Bacchi CE.
Ann Diagn Pathol.
2013;
17
(3):
250-5
-
Follicular lymphoma in young adults: a clinicopathological and molecular study of 200 patients.
Duarte IX,
Domeny-Duarte P, Wludarski SC, Natkunam Y, Bacchi CE.
Mod Pathol.
2013
-
Indolent T-lymphoblastic proliferation (iT-LBP): a review of clinical and pathologic features and distinction from malignant T-lymphoblastic lymphoma.
Ohgami RS,
Arber DA, Zehnder JL, Natkunam Y, Warnke RA.
Adv Anat Pathol.
2013;
20
(3):
137-40
-
Integration of genomic medicine into pathology residency training: the stanford open curriculum.
Schrijver I,
Natkunam Y, Galli S, Boyd SD.
J Mol Diagn.
2013;
15
(2):
141-8
-
Selective immunophenotyping for diagnosis of B-cell neoplasms: immunohistochemistry and flow cytometry strategies and results.
Boyd SD,
Natkunam Y, Allen JR, Warnke RA.
Appl Immunohistochem Mol Morphol.
2013;
21
(2):
116-31
-
Syk-induced phosphatidylinositol-3-kinase activation in Epstein-Barr virus posttransplant lymphoproliferative disorder.
Hatton O,
Lambert SL, Phillips LK, Vaysberg M, Natkunam Y, Esquivel CO, Krams SM, Martinez OM.
Am J Transplant.
2013;
13
(4):
883-90
-
The spectrum of lymphoblastic, nodal and extranodal T-cell lymphomas: characteristic features and diagnostic dilemmas.
Savage NM,
Johnson RC, Natkunam Y.
Hum Pathol.
2013;
44
(4):
451-71
-
Usefulness of HGAL and LMO2 Immunohistochemistry in the Identification of Follicular Lymphomas of the Non-Gastric Gastrointestinal Tract.
Chapman-Fredricks J,
Younes SF, Fan YS, Sandoval-Sus JD, Natkunam Y, Lossos IS.
Appl Immunohistochem Mol Morphol.
2013;
21
(3):
200-4
-
Aggressive EBV-associated lymphoproliferative disorder: a prodrome to diffuse large B-cell lymphoma?
Batra R,
Medeiros BC, Zehnder JL, Warnke RA, Natkunam Y.
Appl Immunohistochem Mol Morphol.
2012;
20
(3):
325-30
-
Cyclin D3 coordinates the cell cycle during differentiation to regulate erythrocyte size and number.
Sankaran VG,
Ludwig LS, Sicinska E, Xu J, Bauer DE, Eng JC, Patterson HC, Metcalf RA, Natkunam Y, Orkin SH, Sicinski P, Lander ES, Lodish HF.
Genes Dev.
2012;
26
(18):
2075-87
-
Expression of the CD2AP adaptor molecule in normal, reactive and neoplastic human tissue.
Rizvi H,
Paterson JC, Tedoldi S, Ramsay A, Calaminici M, Natkunam Y, Lonardi S, Tan SY, Campbell L, Hansmann ML, Jones D, Dikic I, Shaw AS, Pileri SA, Stein H, Mason DY, Facchetti F, Marafioti T.
Pathologica.
2012;
104
(2):
56-64
-
Identification of LMO2 transcriptome and interactome in diffuse large B-cell lymphoma.
Cubedo E,
Gentles AJ, Huang C, Natkunam Y, Bhatt S, Lu X, Jiang X, Romero-Camarero I, Freud A, Zhao S, Bacchi CE, Martínez-Climent JA, Sánchez-García I, Melnick A, Lossos IS.
Blood.
2012;
119
(23):
5478-91
-
IgG4-related systemic sclerosing disease of the ocular adnexa: a potential mimic of ocular lymphoma.
Karamchandani JR,
Younes SF, Warnke RA, Natkunam Y.
Am J Clin Pathol.
2012;
137
(5):
699-711
-
LIM domain only 2 protein expression, LMO2 germline genetic variation, and overall survival in diffuse large B-cell lymphoma in the pre-rituximab era.
Cerhan JR,
Natkunam Y, Morton LM, Maurer MJ, Asmann Y, Habermann TM, Vasef MA, Cozen W, Lynch CF, Allmer C, Slager SL, Lossos IS, Chanock SJ, Rothman N, Hartge P, Dogan A, Wang SS.
Leuk Lymphoma.
2012;
53
(6):
1105-12
-
Lack of association of tumor-associated macrophages with clinical outcome in patients with classical Hodgkin's lymphoma.
Azambuja D,
Natkunam Y, Biasoli I, Lossos IS, Anderson MW, Morais JC, Spector N.
Ann Oncol.
2012;
23
(3):
736-42
-
TdT+ T-lymphoblastic populations are increased in Castleman disease, in Castleman disease in association with follicular dendritic cell tumors, and in angioimmunoblastic T-cell lymphoma.
Ohgami RS,
Zhao S, Ohgami JK, Leavitt MO, Zehnder JL, West RB, Arber DA, Natkunam Y, Warnke RA.
Am J Surg Pathol.
2012;
36
(11):
1619-28
-
The contribution of HGAL/GCET2 in immunohistological algorithms: a comparative study in 424 cases of nodal diffuse large B-cell lymphoma.
Gualco G,
Bacchi LM, Domeny-Duarte P, Natkunam Y, Bacchi CE.
Mod Pathol.
2012;
25
(11):
1439-45
-
The spectrum of B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma: a description of 10 cases.
Gualco G,
Natkunam Y, Bacchi CE.
Mod Pathol.
2012;
25
(5):
661-74
-
Clinicopathologic and molecular features of 122 Brazilian cases of nodal and extranodal NK/T-cell lymphoma, nasal type, with EBV subtyping analysis.
Gualco G,
Domeny-Duarte P, Chioato L, Barber G, Natkunam Y, Bacchi CE.
Am J Surg Pathol.
2011;
35
(8):
1195-203
-
HGAL protein expression persists in disorders of germinal center dissolution: potential role of HGAL in the germinal center microenvironment.
Temmins C,
Zhao S, Lossos IS, Natkunam Y.
Appl Immunohistochem Mol Morphol.
2011;
19
(3):
266-72
-
Immunostaining to identify molecular subtypes of diffuse large B-cell lymphoma in a population-based epidemiologic study in the pre-rituximab era.
Morton LM,
Cerhan JR, Hartge P, Vasef MA, Neppalli VT, Natkunam Y, Dogan A, Dave BJ, Jain S, Levy R, Lossos IS, Cozen W, Davis S, Schenk MJ, Maurer MJ, Lynch CF, Rothman N, Chatterjee N, Yu K, Staudt LM, Weisenburger DD, Wang SS.
Int J Mol Epidemiol Genet.
2011;
2
(3):
245-52
-
LMO2 protein expression predicts survival in patients with rheumatoid arthritis and diffuse large B-cell lymphoma.
Baecklund E,
Backlin C, Mansouri M, Klareskog L, Askling J, Iliadou AN, Enblad G, Lossos IS, Natkunam Y, Rosenquist R.
Leuk Lymphoma.
2011;
52
(6):
1146-9
-
MicroRNAs are independent predictors of outcome in diffuse large B-cell lymphoma patients treated with R-CHOP.
Alencar AJ,
Malumbres R, Kozloski GA, Advani R, Talreja N, Chinichian S, Briones J, Natkunam Y, Sehn LH, Gascoyne RD, Tibshirani R, Lossos IS.
Clin Cancer Res.
2011;
17
(12):
4125-35
-
Prediction of survival in diffuse large B-cell lymphoma based on the expression of 2 genes reflecting tumor and microenvironment.
Alizadeh AA,
Gentles AJ, Alencar AJ, Liu CL, Kohrt HE, Houot R, Goldstein MJ, Zhao S, Natkunam Y, Advani RH, Gascoyne RD, Briones J, Tibshirani RJ, Myklebust JH, Plevritis SK, Lossos IS, Levy R.
Blood.
2011;
118
(5):
1350-8
-
T-cell lymphomas: a tale of heterogeneity masking clarity.
Natkunam Y,
Leuk Lymphoma.
2011;
52
(1):
1-2
-
The efficacy of HGAL and LMO2 in the separation of lymphomas derived from small B cells in nodal and extranodal sites, including the bone marrow.
Younes SF,
Beck AH, Ohgami RS, Lossos IS, Levy R, Warnke RA, Natkunam Y.
Am J Clin Pathol.
2011;
135
(5):
697-708
-
Building "tissue" microarrays from suspension cells.
Zhao S,
Natkunam Y.
Methods Mol Biol.
2010:
664
93-101
-
C-C chemokine receptor 1 expression in human hematolymphoid neoplasia.
Anderson MW,
Zhao S, Ai WZ, Tibshirani R, Levy R, Lossos IS, Natkunam Y.
Am J Clin Pathol.
2010;
133
(3):
473-83
-
CD81 protein is expressed at high levels in normal germinal center B cells and in subtypes of human lymphomas.
Luo RF,
Zhao S, Tibshirani R, Myklebust JH, Sanyal M, Fernandez R, Gratzinger D, Marinelli RJ, Lu ZS, Wong A, Levy R, Levy S, Natkunam Y.
Hum Pathol.
2010;
41
(2):
271-80
-
Characterization of D-cyclin proteins in hematolymphoid neoplasms: lack of specificity of cyclin-D2 and D3 expression in lymphoma subtypes.
Metcalf RA,
Zhao S, Anderson MW, Lu ZS, Galperin I, Marinelli RJ, Cherry AM, Lossos IS, Natkunam Y.
Mod Pathol.
2010;
23
(3):
420-33
-
Efficacy of bortezomib in a direct xenograft model of primary effusion lymphoma.
Sarosiek KA,
Cavallin LE, Bhatt S, Toomey NL, Natkunam Y, Blasini W, Gentles AJ, Ramos JC, Mesri EA, Lossos IS.
Proc Natl Acad Sci U S A.
2010;
107
(29):
13069-74
-
Embryonic stem cell-derived endothelial cells engraft into the ischemic hindlimb and restore perfusion.
Huang NF,
Niiyama H, Peter C, De A, Natkunam Y, Fleissner F, Li Z, Rollins MD, Wu JC, Gambhir SS, Cooke JP.
Arterioscler Thromb Vasc Biol.
2010;
30
(5):
984-91
-
Expression of LMO2 is associated with t(14;18)/IGH-BCL2 fusion but not BCL6 translocations in diffuse large B-cell lymphoma.
Durnick DK,
Law ME, Maurer MJ, Natkunam Y, Levy R, Lossos IS, Kurtin PJ, McPhail ED.
Am J Clin Pathol.
2010;
134
(2):
278-81
-
Immunoarchitectural patterns in follicular lymphoma: efficacy of HGAL and LMO2 in the detection of the interfollicular and diffuse components.
Younes SF,
Beck AH, Lossos IS, Levy R, Warnke RA, Natkunam Y.
Am J Surg Pathol.
2010;
34
(9):
1266-76
-
Lymphoma cell VEGFR2 expression detected by immunohistochemistry predicts poor overall survival in diffuse large B cell lymphoma treated with immunochemotherapy (R-CHOP).
Gratzinger D,
Advani R, Zhao S, Talreja N, Tibshirani RJ, Shyam R, Horning S, Sehn LH, Farinha P, Briones J, Lossos IS, Gascoyne RD, Natkunam Y.
Br J Haematol.
2010;
148
(2):
235-44
-
Oral and extraoral plasmablastic lymphoma: similarities and differences in clinicopathologic characteristics.
Hansra D,
Montague N, Stefanovic A, Akunyili I, Harzand A, Natkunam Y, de la Ossa M, Byrne GE, Lossos IS.
Am J Clin Pathol.
2010;
134
(5):
710-9
-
PD-1 expression in T-cell lymphomas and reactive lymphoid entities: potential overlap in staining patterns between lymphoma and viral lymphadenitis.
Krishnan C,
Warnke RA, Arber DA, Natkunam Y.
Am J Surg Pathol.
2010;
34
(2):
178-89
-
Programmed death 1 expression in variant immunoarchitectural patterns of nodular lymphocyte predominant Hodgkin lymphoma: comparison with CD57 and lymphomas in the differential diagnosis.
Churchill HR,
Roncador G, Warnke RA, Natkunam Y.
Hum Pathol.
2010;
41
(12):
1726-34
-
The inducible T-cell co-stimulator molecule is expressed on subsets of T cells and is a new marker of lymphomas of T follicular helper cell-derivation.
Marafioti T,
Paterson JC, Ballabio E, Chott A, Natkunam Y, Rodriguez-Justo M, Plonquet A, Rodriguez-Pinilla SM, Klapper W, Hansmann ML, Pileri SA, Isaacson PG, Stein H, Piris MA, Mason DY, Gaulard P.
Haematologica.
2010;
95
(3):
432-9
-
Characterization of c-Maf transcription factor in normal and neoplastic hematolymphoid tissue and its relevance in plasma cell neoplasia.
Natkunam Y,
Tedoldi S, Paterson JC, Zhao S, Rodriguez-Justo M, Beck AH, Siebert R, Mason DY, Marafioti T.
Am J Clin Pathol.
2009;
132
(3):
361-71
-
Extracellular signal-regulated kinase positively regulates the oncogenic activity of MCT-1 in diffuse large B-cell lymphoma.
Dai B,
Zhao XF, Hagner P, Shapiro P, Mazan-Mamczarz K, Zhao S, Natkunam Y, Gartenhaus RB.
Cancer Res.
2009;
69
(19):
7835-43
-
Gray zones around diffuse large B cell lymphoma. Conclusions based on the workshop of the XIV meeting of the European Association for Hematopathology and the Society of Hematopathology in Bordeaux, France.
Quintanilla-Martinez L,
de Jong D, de Mascarel A, Hsi ED, Kluin P, Natkunam Y, Parrens M, Pileri S, Ott G.
J Hematop.
2009;
2
(4):
211-36
-
Human germinal center-associated lymphoma protein expression is associated with improved failure-free survival in Brazilian patients with classical Hodgkin lymphoma.
Azambuja D,
Lossos IS, Biasoli I, Morais JC, Britto L, Scheliga A, Pulcheri W, Natkunam Y, Spector N.
Leuk Lymphoma.
2009;
50
(11):
1830-6
-
Immunoarchitectural patterns in nodal marginal zone B-cell lymphoma: a study of 51 cases.
Salama ME,
Lossos IS, Warnke RA, Natkunam Y.
Am J Clin Pathol.
2009;
132
(1):
39-49
-
Lack of utility of CD20 immunohistochemistry in staging bone marrow biopsies for diffuse large B-cell lymphoma.
Baiyee D,
Warnke R, Natkunam Y.
Appl Immunohistochem Mol Morphol.
2009;
17
(2):
93-5
-
Low stage follicular lymphoma: biologic and clinical characterization according to nodal or extranodal primary origin.
Weinberg OK,
Ma L, Seo K, Beck AH, Pai RK, Morales A, Kim Y, Sundram U, Tan D, Horning SJ, Hoppe RT, Natkunam Y, Arber DA.
Am J Surg Pathol.
2009;
33
(4):
591-8
-
Microtubule-associated protein-2 is a sensitive marker of primary and metastatic neuroblastoma.
Krishnan C,
Higgins JP, West RB, Natkunam Y, Heerema-McKenney A, Arber DA.
Am J Surg Pathol.
2009;
33
(11):
1695-704
-
Nanofluidic proteomic assay for serial analysis of oncoprotein activation in clinical specimens.
Fan AC,
Deb-Basu D, Orban MW, Gotlib JR, Natkunam Y, O'Neill R, Padua RA, Xu L, Taketa D, Shirer AE, Beer S, Yee AX, Voehringer DW, Felsher DW.
Nat Med.
2009;
15
(5):
566-71
-
The transcription factor LMO2 is a robust marker of vascular endothelium and vascular neoplasms and selected other entities.
Gratzinger D,
Zhao S, West R, Rouse RV, Vogel H, Gil EC, Levy R, Lossos IS, Natkunam Y.
Am J Clin Pathol.
2009;
131
(2):
264-78
-
Tissue microarrays from bone marrow aspirates for high-throughput assessment of immunohistologic markers in pediatric acute leukemia.
Hazard FK,
Zhao S, Schiffman JD, Lacayo NJ, Dahl GV, Natkunam Y.
Pediatr Dev Pathol.
2008 Jul-Aug;
11
(4):
283-90
-
Expression of HGAL in primary cutaneous large B-cell lymphomas: evidence for germinal center derivation of primary cutaneous follicular lymphoma.
Xie X,
Sundram U, Natkunam Y, Kohler S, Hoppe RT, Kim YH, Cook JR, Hammel J, Swerdlow SH, Guitart J, Smith MD, Bosler D, Listinsky C, Lossos IS, Hsi ED.
Mod Pathol.
2008;
21
(6):
653-9
-
Expression of the human germinal-centre-associated lymphoma protein in diffuse large B-cell lymphomas in patients with rheumatoid arthritis.
Baecklund E,
Natkunam Y, Backlin C, Iliadou A, Askling J, Ekbom A, Feltelius N, Klareskog L, Enblad G, Lossos IS, Levy R, Sundström C, Rosenquist R.
Br J Haematol.
2008;
141
(1):
69-72
-
Immunohistochemical characterization of nasal-type extranodal NK/T-cell lymphoma using a tissue microarray: an analysis of 84 cases.
Schwartz EJ,
Molina-Kirsch H, Zhao S, Marinelli RJ, Warnke RA, Natkunam Y.
Am J Clin Pathol.
2008;
130
(3):
343-51
-
LMO2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with anthracycline-based chemotherapy with and without rituximab.
Natkunam Y,
Farinha P, Hsi ED, Hans CP, Tibshirani R, Sehn LH, Connors JM, Gratzinger D, Rosado M, Zhao S, Pohlman B, Wongchaowart N, Bast M, Avigdor A, Schiby G, Nagler A, Byrne GE, Levy R, Gascoyne RD, Lossos IS.
J Clin Oncol.
2008;
26
(3):
447-54
-
PTP1B is a negative regulator of interleukin 4-induced STAT6 signaling.
Lu X,
Malumbres R, Shields B, Jiang X, Sarosiek KA, Natkunam Y, Tiganis T, Lossos IS.
Blood.
2008;
112
(10):
4098-108
-
Paraffin-based 6-gene model predicts outcome in diffuse large B-cell lymphoma patients treated with R-CHOP.
Malumbres R,
Chen J, Tibshirani R, Johnson NA, Sehn LH, Natkunam Y, Briones J, Advani R, Connors JM, Byrne GE, Levy R, Gascoyne RD, Lossos IS.
Blood.
2008;
111
(12):
5509-14
-
Prognostic significance of VEGF, VEGF receptors, and microvessel density in diffuse large B cell lymphoma treated with anthracycline-based chemotherapy.
Gratzinger D,
Zhao S, Tibshirani RJ, Hsi ED, Hans CP, Pohlman B, Bast M, Avigdor A, Schiby G, Nagler A, Byrne GE, Lossos IS, Natkunam Y.
Lab Invest.
2008;
88
(1):
38-47
-
The Stanford Tissue Microarray Database.
Marinelli RJ,
Montgomery K, Liu CL, Shah NH, Prapong W, Nitzberg M, Zachariah ZK, Sherlock GJ, Natkunam Y, West RB, van de Rijn M, Brown PO, Ball CA.
Nucleic Acids Res.
2008;
36
(Database issue):
D871-7
-
Expression of the RNA-binding protein VICKZ in normal hematopoietic tissues and neoplasms.
Natkunam Y,
Vainer G, Chen J, Zhao S, Marinelli RJ, Hammer AS, Hamilton-Dutoit S, Pikarsky E, Amir G, Levy R, Yisraeli JK, Lossos IS.
Haematologica.
2007;
92
(2):
176-83
-
Expression of the human germinal center-associated lymphoma (HGAL) protein identifies a subset of classic Hodgkin lymphoma of germinal center derivation and improved survival.
Natkunam Y,
Hsi ED, Aoun P, Zhao S, Elson P, Pohlman B, Naushad H, Bast M, Levy R, Lossos IS.
Blood.
2007;
109
(1):
298-305
-
International standardized approach for flow cytometric residual disease monitoring in chronic lymphocytic leukaemia.
Rawstron AC,
Villamor N, Ritgen M, Böttcher S, Ghia P, Zehnder JL, Lozanski G, Colomer D, Moreno C, Geuna M, Evans PA, Natkunam Y, Coutre SE, Avery ED, Rassenti LZ, Kipps TJ, Caligaris-Cappio F, Kneba M, Byrd JC, Hallek MJ, Montserrat E, Hillmen P.
Leukemia.
2007;
21
(5):
956-64
-
Mast cell tryptase and microphthalmia transcription factor effectively discriminate cutaneous mast cell disease from myeloid leukemia cutis.
Sundram UN,
Natkunam Y.
J Cutan Pathol.
2007;
34
(4):
289-95
-
Microvessel density and expression of vascular endothelial growth factor and its receptors in diffuse large B-cell lymphoma subtypes.
Gratzinger D,
Zhao S, Marinelli RJ, Kapp AV, Tibshirani RJ, Hammer AS, Hamilton-Dutoit S, Natkunam Y.
Am J Pathol.
2007;
170
(4):
1362-9
-
Oncogenic regulators and substrates of the anaphase promoting complex/cyclosome are frequently overexpressed in malignant tumors.
Lehman NL,
Tibshirani R, Hsu JY, Natkunam Y, Harris BT, West RB, Masek MA, Montgomery K, van de Rijn M, Jackson PK.
Am J Pathol.
2007;
170
(5):
1793-805
-
Selective loss of B-cell phenotype in lymphocyte predominant Hodgkin lymphoma.
Tedoldi S,
Mottok A, Ying J, Paterson JC, Cui Y, Facchetti F, van Krieken JH, Ponzoni M, Ozkal S, Masir N, Natkunam Y, Pileri S, Hansmann ML, Mason D, Tao Q, Marafioti T.
J Pathol.
2007;
213
(4):
429-40
-
The biology of the germinal center.
Natkunam Y,
Hematology Am Soc Hematol Educ Program.
2007:
210-5
-
The oncoprotein LMO2 is expressed in normal germinal-center B cells and in human B-cell lymphomas.
Natkunam Y,
Zhao S, Mason DY, Chen J, Taidi B, Jones M, Hammer AS, Hamilton Dutoit S, Lossos IS, Levy R.
Blood.
2007;
109
(4):
1636-42
-
The utility of PAX5 immunohistochemistry in the diagnosis of undifferentiated malignant neoplasms.
Jensen KC,
Higgins JP, Montgomery K, Kaygusuz G, van de Rijn M, Natkunam Y.
Mod Pathol.
2007;
20
(8):
871-7
-
Bringing pathobiology into focus.
Turner JR,
Maitra A, Natkunam Y, Rubin BP, Rubin MA, Teitell MA.
Lab Invest.
2006;
86
(7):
632
-
CD10 expression in peripheral T-cell lymphomas complicated by a proliferation of large B-cells.
Reichard KK,
Schwartz EJ, Higgins JP, Narasimhan B, Warnke RA, Natkunam Y.
Mod Pathol.
2006;
19
(3):
337-43
-
EBV can protect latently infected B cell lymphomas from death receptor-induced apoptosis.
Snow AL,
Lambert SL, Natkunam Y, Esquivel CO, Krams SM, Martinez OM.
J Immunol.
2006;
177
(5):
3283-93
-
Jaw1/LRMP, a germinal centre-associated marker for the immunohistological study of B-cell lymphomas.
Tedoldi S,
Paterson JC, Cordell J, Tan SY, Jones M, Manek S, Dei Tos AP, Roberton H, Masir N, Natkunam Y, Pileri SA, Facchetti F, Hansmann ML, Mason DY, Marafioti T.
J Pathol.
2006;
209
(4):
454-63
-
Loss of CD19 expression in B-cell neoplasms.
Masir N,
Marafioti T, Jones M, Natkunam Y, Rüdiger T, Hansmann ML, Mason DY.
Histopathology.
2006;
48
(3):
239-46
-
Low CD27 expression in plasma cell dyscrasias correlates with high-risk disease: an immunohistochemical analysis.
Morgan TK,
Zhao S, Chang KL, Haddix TL, Domanay E, Cornbleet PJ, Arber DA, Natkunam Y.
Am J Clin Pathol.
2006;
126
(4):
545-51
-
Prognostic immunohistologic markers in human tumors: why are so few used in clinical practice?
Natkunam Y,
Mason DY.
Lab Invest.
2006;
86
(8):
742-7
-
The differential expression of LCK and BAFF-receptor and their role in apoptosis in human lymphomas.
Paterson JC,
Tedoldi S, Craxton A, Jones M, Hansmann ML, Collins G, Roberton H, Natkunam Y, Pileri S, Campo E, Clark EA, Mason DY, Marafioti T.
Haematologica.
2006;
91
(6):
772-80
-
Transmembrane adaptor molecules: a new category of lymphoid-cell markers.
Tedoldi S,
Paterson JC, Hansmann ML, Natkunam Y, Rüdiger T, Angelisova P, Du MQ, Roberton H, Roncador G, Sanchez L, Pozzobon M, Masir N, Barry R, Pileri S, Mason DY, Marafioti T, Horejsí V.
Blood.
2006;
107
(1):
213-21
-
Treatment of verruca vulgaris with topical cidofovir in an immunocompromised patient: a case report and review of the literature.
Cha S,
Johnston L, Natkunam Y, Brown J.
Transpl Infect Dis.
2005 Sep-Dec;
7
(3-4):
158-61
-
A novel method for making "tissue" microarrays from small numbers of suspension cells.
Montgomery K,
Zhao S, van de Rijn M, Natkunam Y.
Appl Immunohistochem Mol Morphol.
2005;
13
(1):
80-4
-
Cytologic diagnosis of Burkitt lymphoma.
Troxell ML,
Bangs CD, Cherry AM, Natkunam Y, Kong CS.
Cancer.
2005;
105
(5):
310-8
-
Expression of CD163 (hemoglobin scavenger receptor) in normal tissues, lymphomas, carcinomas, and sarcomas is largely restricted to the monocyte/macrophage lineage.
Nguyen TT,
Schwartz EJ, West RB, Warnke RA, Arber DA, Natkunam Y.
Am J Surg Pathol.
2005;
29
(5):
617-24
-
Expression of the bcl-6 and MUM1/IRF4 proteins correlate with overall and disease-specific survival in patients with primary cutaneous large B-cell lymphoma: a tissue microarray study.
Sundram U,
Kim Y, Mraz-Gernhard S, Hoppe R, Natkunam Y, Kohler S.
J Cutan Pathol.
2005;
32
(3):
227-34
-
Expression of the human germinal center-associated lymphoma (HGAL) protein, a new marker of germinal center B-cell derivation.
Natkunam Y,
Lossos IS, Taidi B, Zhao S, Lu X, Ding F, Hammer AS, Marafioti T, Byrne GE, Levy S, Warnke RA, Levy R.
Blood.
2005;
105
(10):
3979-86
-
Expression pattern of intracellular leukocyte-associated proteins in primary mediastinal B cell lymphoma.
Marafioti T,
Pozzobon M, Hansmann ML, Gaulard P, Barth TF, Copie-Bergman C, Roberton H, Ventura R, Martín-Subero JI, Gascoyne RD, Pileri SA, Siebert R, Hsi ED, Natkunam Y, Möller P, Mason DY.
Leukemia.
2005;
19
(5):
856-61
-
Follicular dendritic cell immunohistochemical markers in angioimmunoblastic T-cell lymphoma.
Troxell ML,
Schwartz EJ, van de Rijn M, Ross DT, Warnke RA, Higgins JP, Natkunam Y.
Appl Immunohistochem Mol Morphol.
2005;
13
(4):
297-303
-
Low levels of Her2/neu expressed by Ewing's family tumor cell lines can redirect cytokine-induced killer cells.
Verneris MR,
Arshi A, Edinger M, Kornacker M, Natkunam Y, Karami M, Cao YA, Marina N, Contag CH, Negrin RS.
Clin Cancer Res.
2005;
11
(12):
4561-70
-
TMA-Combiner, a simple software tool to permit analysis of replicate cores on tissue microarrays.
Liu CL,
Montgomery KD, Natkunam Y, West RB, Nielsen TO, Cheang MC, Turbin DA, Marinelli RJ, van de Rijn M, Higgins JP.
Mod Pathol.
2005;
18
(12):
1641-8
-
The NFATc1 transcription factor is widely expressed in white cells and translocates from the cytoplasm to the nucleus in a subset of human lymphomas.
Marafioti T,
Marafiot T, Pozzobon M, Hansmann ML, Ventura R, Pileri SA, Roberton H, Gesk S, Gaulard P, Barth TF, Du MQ, Leoncini L, Möller P, Natkunam Y, Siebert R, Mason DY.
Br J Haematol.
2005;
128
(3):
333-42
-
Utility of syndecan-1 (CD138) expression in the diagnosis of undifferentiated malignant neoplasms: a tissue microarray study of 1,754 cases.
Kambham N,
Kong C, Longacre TA, Natkunam Y.
Appl Immunohistochem Mol Morphol.
2005;
13
(4):
304-10
-
Atypical cellular disorders.
McClain KL,
Natkunam Y, Swerdlow SH.
Hematology Am Soc Hematol Educ Program.
2004:
283-96
-
Expression pattern of FCRL (FREB, FcRX) in normal and neoplastic human B cells.
Masir N,
Jones M, Pozzobon M, Marafioti T, Volkova OY, Mechetina LV, Hansmann ML, Natkunam Y, Taranin AV, Mason DY.
Br J Haematol.
2004;
127
(3):
335-43
-
Immunophenotypic and genotypic characterization of progression in follicular lymphomas.
Natkunam Y,
Soslow R, Matolcsy A, Dolezal M, Bhargava V, Knowles DM, Warnke R.
Appl Immunohistochem Mol Morphol.
2004;
12
(2):
97-104
-
Intracellular signalling molecules as immunohistochemical markers of normal and neoplastic human leucocytes in routine biopsy samples.
Pozzobon M,
Marafioti T, Hansmann ML, Natkunam Y, Mason DY.
Br J Haematol.
2004;
124
(4):
519-33
-
Characterization of variant patterns of nodular lymphocyte predominant hodgkin lymphoma with immunohistologic and clinical correlation.
Fan Z,
Natkunam Y, Bair E, Tibshirani R, Warnke RA.
Am J Surg Pathol.
2003;
27
(10):
1346-56
-
Expression of the B-cell proliferation marker MUM1 by melanocytic lesions and comparison with S100, gp100 (HMB45), and MelanA.
Sundram U,
Harvell JD, Rouse RV, Natkunam Y.
Mod Pathol.
2003;
16
(8):
802-10
-
Plasmablastic lymphoma presenting in a human immunodeficiency virus-negative patient: a case report.
Nguyen DD,
Loo BW, Tillman G, Natkunam Y, Cao TM, Vaughan W, Dorfman RF, Goffinet DR, Jacobs CD, Advani RH.
Ann Hematol.
2003;
82
(8):
521-5
-
Rapamycin inhibits the interleukin 10 signal transduction pathway and the growth of Epstein Barr virus B-cell lymphomas.
Nepomuceno RR,
Balatoni CE, Natkunam Y, Snow AL, Krams SM, Martinez OM.
Cancer Res.
2003;
63
(15):
4472-80
-
Rituximab in lymphocyte-predominant Hodgkin disease: results of a phase 2 trial.
Ekstrand BC,
Lucas JB, Horwitz SM, Fan Z, Breslin S, Hoppe RT, Natkunam Y, Bartlett NL, Horning SJ.
Blood.
2003;
101
(11):
4285-9
-
Apoptosis stimulating protein of p53 (ASPP2) expression differs in diffuse large B-cell and follicular center lymphoma: correlation with clinical outcome.
Lossos IS,
Natkunam Y, Levy R, Lopez CD.
Leuk Lymphoma.
2002;
43
(12):
2309-17
-
Epstein-Barr virus infection is associated with endothelial Bcl-2 expression in transplant liver allografts.
Millan MT,
Natkunam Y, Clarke-Katzenberg R, Desai D, Prapong W, So SK, Esquivel CO, Sibley R, Ferran C, Martinez OM.
Transplantation.
2002;
73
(3):
465-9
-
Large atypical cells of lymphomatoid papulosis are CD56-negative: a study of 18 cases.
Harvell J,
Vaseghi M, Natkunam Y, Kohler S, Kim Y.
J Cutan Pathol.
2002;
29
(2):
88-92
-
Software tools for high-throughput analysis and archiving of immunohistochemistry staining data obtained with tissue microarrays.
Liu CL,
Prapong W, Natkunam Y, Alizadeh A, Montgomery K, Gilks CB, van de Rijn M.
Am J Pathol.
2002;
161
(5):
1557-65
-
The usefulness of immunohistochemistry in the diagnosis of follicular lymphoma in bone marrow biopsy specimens.
West RB,
Warnke RA, Natkunam Y.
Am J Clin Pathol.
2002;
117
(4):
636-43
-
A unique AML1 (CBF2A) rearrangement, t(1;21)(p32;q22), observed in a patient with acute myelomonocytic leukemia.
Cherry AM,
Bangs CD, Jones P, Hall S, Natkunam Y.
Cancer Genet Cytogenet.
2001;
129
(2):
155-60
-
Analysis of MUM1/IRF4 protein expression using tissue microarrays and immunohistochemistry.
Natkunam Y,
Warnke RA, Montgomery K, Falini B, van De Rijn M.
Mod Pathol.
2001;
14
(7):
686-94
-
Angiocentric lymphomas (lymphomatous vasculitis).
Natkunam Y,
Warnke RA.
Semin Diagn Pathol.
2001;
18
(1):
67-77
-
Durable remission in recurrent T-cell-rich B-cell lymphoma with the anti-CD20 antibody rituximab.
Natkunam Y,
Stanton TS, Warnke RA, Horning SJ.
Clin Lymphoma.
2001;
2
(3):
185-7
-
Expression of a single gene, BCL-6, strongly predicts survival in patients with diffuse large B-cell lymphoma.
Lossos IS,
Jones CD, Warnke R, Natkunam Y, Kaizer H, Zehnder JL, Tibshirani R, Levy R.
Blood.
2001;
98
(4):
945-51
-
Modified cyclophosphamide, hydroxydaunorubicin, vincristine, and prednisone therapy for posttransplantation lymphoproliferative disease in pediatric patients undergoing solid organ transplantation.
Suryanarayan K,
Natkunam Y, Berry G, Bangs CD, Cherry A, Dahl G.
J Pediatr Hematol Oncol.
2001;
23
(7):
452-5
-
Natural killer cell precursor acute lymphoma/leukemia presenting in an infant.
Natkunam Y,
Cherry AM, Cornbleet PJ.
Arch Pathol Lab Med.
2001;
125
(3):
413-8
-
Natural killer/natural killer-like T-cell lymphoma, CD56+, presenting in the skin: an increasingly recognized entity with an aggressive course.
Mraz-Gernhard S,
Natkunam Y, Hoppe RT, LeBoit P, Kohler S, Kim YH.
J Clin Oncol.
2001;
19
(8):
2179-88
-
Blastic/blastoid transformation of follicular lymphoma: immunohistologic and molecular analyses of five cases.
Natkunam Y,
Warnke RA, Zehnder JL, Jones CD, Milatovich-Cherry A, Cornbleet PJ.
Am J Surg Pathol.
2000;
24
(4):
525-34
-
Co-expression of CD56 and CD30 in lymphomas with primary presentation in the skin: clinicopathologic, immunohistochemical and molecular analyses of seven cases.
Natkunam Y,
Warnke RA, Haghighi B, Su LD, Le Boit PE, Kim YH, Kohler S.
J Cutan Pathol.
2000;
27
(8):
392-9
-
Immunoblot analysis of CD34 expression in histologically diverse neoplasms.
Natkunam Y,
Rouse RV, Zhu S, Fisher C, van De Rijn M.
Am J Pathol.
2000;
156
(1):
21-7
-
Utility of paraffin section immunohistochemistry for C-KIT (CD117) in the differential diagnosis of systemic mast cell disease involving the bone marrow.
Natkunam Y,
Rouse RV.
Am J Surg Pathol.
2000;
24
(1):
81-91
-
Aggressive cutaneous NK and NK-like T-cell lymphomas: clinicopathologic, immunohistochemical, and molecular analyses of 12 cases.
Natkunam Y,
Smoller BR, Zehnder JL, Dorfman RF, Warnke RA.
Am J Surg Pathol.
1999;
23
(5):
571-81
-
Aggressive natural killer-like T-cell malignancy with leukemic presentation following solid organ transplantation.
Natkunam Y,
Warnke RA, Zehnder JL, Cornbleet PJ.
Am J Clin Pathol.
1999;
111
(5):
663-71
-
Epstein-Barr virus strain type and latent membrane protein 1 gene deletions in lymphomas in patients with rheumatic diseases.
Natkunam Y,
Elenitoba-Johnson KS, Kingma DW, Kamel OW.
Arthritis Rheum.
1997;
40
(6):
1152-6
-
Simultaneous activation of Ig and Oct-2 synthesis and reduction of surface MHC class II expression by IL-6.
Natkunam Y,
Zhang X, Liu Z, Chen-Kiang S.
J Immunol.
1994;
153
(8):
3476-84
-
Nuclear signaling by interleukin-6.
Chen-Kiang S,
Hsu W, Natkunam Y, Zhang X.
Curr Opin Immunol.
1993;
5
(1):
124-8
Navigation for This Section: Stanford Hospital & Clinics
Additional Links: Hospital Services
FIND A PHYSICIAN
Help